Rivaroxaban Tablet

Rivaroxaban Tablet

Categories : Cardiovascular System

Product Packaging : 10 / 30 tablets

Product Composition : 10 mg, 15 mg, 20 mg

Send Message

Rivaroxaban Tablets are advanced oral anticoagulant medicines used for the prevention and treatment of thromboembolic disorders. The formulation acts as a direct Factor Xa inhibitor, helping reduce blood clot formation and supporting effective management of cardiovascular and vascular conditions. Genliva Wellness LLP supplies premium-quality Rivaroxaban Tablets for Global Pharmaceutical Markets.

This medicine is widely prescribed for patients at risk of deep vein thrombosis (DVT), pulmonary embolism (PE), stroke associated with non-valvular atrial fibrillation, and recurrent thromboembolic events. As a reliable Rivaroxaban Tablet Exporter from India, we serve pharmaceutical distributors, importers, and healthcare organizations across international markets.

Manufactured using advanced pharmaceutical technology and stringent quality standards, the product delivers consistent efficacy and safety. Genliva Wellness LLP is a trusted Rivaroxaban Tablet Manufacturer in Gujarat, India, offering contract manufacturing and export solutions for cardiovascular and anticoagulant therapies.

Rivaroxaban Tablets are formulated to provide effective anticoagulant therapy and thromboembolic protection.

  • Contains Rivaroxaban as the active ingredient
  • Direct Factor Xa inhibitor
  • Oral anticoagulant formulation
  • Available in multiple strengths
  • Suitable for long-term therapy
  • Consistent therapeutic performance

Rivaroxaban Tablets are used for the prevention and treatment of blood clot-related conditions.

  • Deep vein thrombosis (DVT)
  • Pulmonary embolism (PE)
  • Stroke prevention in atrial fibrillation
  • Venous thromboembolism (VTE)
  • Post-operative thrombosis prevention

Rivaroxaban Tablets provide effective protection against thromboembolic complications and cardiovascular risks.

  • Helps prevent blood clot formation
  • Supports stroke risk reduction
  • Effective oral anticoagulant therapy

whatsapp-app